Watch on demand DIA 2021 Session #2

What's the best way for an organization to prepare for the continued digitization and decentralization of trials?

Join a panel of experts across Bristol-Myers Squibb, Cognizant, and Medable as they lead attendees through the key questions and strategies used to set and define digital and decentralized drug development strategies. 

Viewers will walk away with a thorough understanding of the benefits and needs of a proper DCT strategy, including:

  • Scale - Portfolio transformation powered by digital outcomes and decision making 
  • Inclusion - Global accessibility, deployment and consistency
  • Speed - What does faster look like in the future?
  • Adoption - What are the current barriers and resistance to adoption?
  • Cost - Strategies to control and reduce timeline and cost variation

Our speakers

Alison (Ali) Holland is Head of Decentralized Clinical Trials at Medable and is chartered to design and expand the end-to-end capabilities.

As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop and implement...

Jared Klingeisen is Vice President of Customer Success at Medable, serving in that role since the early days of the company in 2018.

Watch on demand